Literature DB >> 20118158

Predictors of the rate of change in disease activity over time in LUMINA, a multiethnic US cohort of patients with systemic lupus erythematosus: LUMINA LXX.

J Zhang1, L A González, J M Roseman, L M Vilá, J D Reveille, G S Alárcon.   

Abstract

The objectives of the present study were (1) to clarify and quantify the relationship between age and disease duration with the rate of change in disease activity over time in patients with systemic lupus erythematosus (SLE) and (2) to explore other possible factors associated with this rate of change. To this end, SLE patients from LUMINA were studied if they had at least three visits in which disease activity (Systemic Lupus Activity Measure-Revised [SLAM-R]) had been ascertained. Variables associated with the rate (slope) of change in disease activity (obtained by regressing the SLAM-R score against the length of time from diagnosis to visit date) were examined by univariable and multivariable analyses. Five hundred and forty two of the 632 patients had at least three SLAM-R score. In multivariable analyses, Whites exhibited the fastest decline in disease activity, Texan Hispanics exhibited the slowest, trailed by the African Americans. Longer disease duration and HLA-DRB1*1503 positivity were associated with a slower decline whereas a greater number of American College of Rheumatology criteria and abnormal laboratory parameters (white blood cell counts, hematocrit and serum creatinine) were associated with a faster decline. These findings complement existing knowledge on SLE disease activity and are potentially useful to clinicians managing these patients.

Entities:  

Mesh:

Year:  2010        PMID: 20118158      PMCID: PMC3964002          DOI: 10.1177/0961203309359289

Source DB:  PubMed          Journal:  Lupus        ISSN: 0961-2033            Impact factor:   2.911


  34 in total

Review 1.  The benefits of early treatment in rheumatoid arthritis: confounding by indication, and the issue of timing.

Authors:  Robert B M Landewé
Journal:  Arthritis Rheum       Date:  2003-01

2.  Systemic lupus erythematosus in three ethnic groups. VII [correction of VIII]. Predictors of early mortality in the LUMINA cohort. LUMINA Study Group.

Authors:  G S Alarcón; G McGwin; H M Bastian; J Roseman; J Lisse; B J Fessler; A W Friedman; J D Reveille
Journal:  Arthritis Rheum       Date:  2001-04

3.  Decreases in anti-double-stranded DNA levels are associated with concurrent flares in patients with systemic lupus erythematosus.

Authors:  A Ho; L S Magder; S G Barr; M Petri
Journal:  Arthritis Rheum       Date:  2001-10

4.  Patterns of disease activity in systemic lupus erythematosus.

Authors:  S G Barr; A Zonana-Nacach; L S Magder; M Petri
Journal:  Arthritis Rheum       Date:  1999-12

5.  Summarizing disease features over time: II. Variability measures of SLEDAI-2K.

Authors:  Dominique Ibañez; Dafna Gladman; Murray Urowitz
Journal:  J Rheumatol       Date:  2006-12-15       Impact factor: 4.666

6.  Prognostic parameters for flare in systemic lupus erythematosus.

Authors:  M J Mirzayan; R E Schmidt; T Witte
Journal:  Rheumatology (Oxford)       Date:  2000-12       Impact factor: 7.580

7.  Prediction of short term mortality in systemic lupus erythematosus with time dependent measures of disease activity.

Authors:  R J Cook; D D Gladman; D Pericak; M B Urowitz
Journal:  J Rheumatol       Date:  2000-08       Impact factor: 4.666

8.  Systemic lupus erythematosus in three ethnic groups. IX. Differences in damage accrual.

Authors:  G S Alarcón; G McGwin; A A Bartolucci; J Roseman; J Lisse; B J Fessler; H M Bastian; A W Friedman; J D Reveille
Journal:  Arthritis Rheum       Date:  2001-12

9.  Immunology of DNA. III. Crithidia luciliae, a simple substrate for the determination of anti-dsDNA with the immunofluorescence technique.

Authors:  L A Aarden; E R de Groot; T E Feltkamp
Journal:  Ann N Y Acad Sci       Date:  1975-06-30       Impact factor: 5.691

10.  Analysis of the relationship between disease activity and damage in patients with systemic lupus erythematosus--a 5-yr prospective study.

Authors:  T Stoll; N Sutcliffe; J Mach; R Klaghofer; D A Isenberg
Journal:  Rheumatology (Oxford)       Date:  2004-05-25       Impact factor: 7.580

View more
  4 in total

1.  Predictors of predominant Lupus Low Disease Activity State (LLDAS-50).

Authors:  H Babaoglu; J Li; D Goldman; L S Magder; M Petri
Journal:  Lupus       Date:  2019-11-06       Impact factor: 2.911

2.  Time to Lupus Low Disease Activity State in the Hopkins Lupus Cohort: Role of African American Ethnicity.

Authors:  Hakan Babaoğlu; Jessica Li; Daniel Goldman; Laurence S Magder; Michelle Petri
Journal:  Arthritis Care Res (Hoboken)       Date:  2020-01-09       Impact factor: 4.794

Review 3.  Measures of adult systemic lupus erythematosus: updated version of British Isles Lupus Assessment Group (BILAG 2004), European Consensus Lupus Activity Measurements (ECLAM), Systemic Lupus Activity Measure, Revised (SLAM-R), Systemic Lupus Activity Questionnaire for Population Studies (SLAQ), Systemic Lupus Erythematosus Disease Activity Index 2000 (SLEDAI-2K), and Systemic Lupus International Collaborating Clinics/American College of Rheumatology Damage Index (SDI).

Authors:  Juanita Romero-Diaz; David Isenberg; Rosalind Ramsey-Goldman
Journal:  Arthritis Care Res (Hoboken)       Date:  2011-11       Impact factor: 4.794

4.  Association of age with health-related quality of life in a cohort of patients with systemic lupus erythematosus: the Georgians Organized Against Lupus study.

Authors:  Laura Plantinga; S Sam Lim; C Barrett Bowling; Cristina Drenkard
Journal:  Lupus Sci Med       Date:  2016-07-19
  4 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.